Suppr超能文献

小儿心脏病学中的介入导管术。

Interventional catheterization in paediatric cardiology.

作者信息

Gatzoulis M A, Rigby M L, Redington A N

机构信息

Department of Paediatric Cardiology, Royal Brompton Hospital National Heart and Lung Institute, London, U.K.

出版信息

Eur Heart J. 1995 Dec;16(12):1767-72. doi: 10.1093/oxfordjournals.eurheartj.a060826.

Abstract

The primary role of interventional procedures in the management of some congenital heart diseases is established and their clinical utility broadens every day. Yesterday's relatively crude procedures have been replaced by safe and more effective techniques. Improvements and new developments in specifically designed paediatric equipment have played a significant role. In order to meet the cardiologist's drive to refine existing techniques and develop new ones, further investment into paediatric cardiac catheterization equipment is mandatory. More and more "heart operations' will be performed in cardiac catheterization laboratories in the future, and this will have clear implications on costs, as most non-surgical techniques are cheaper than surgery, and hospitalization is much shorter. New methods, tested within research protocols in specialized centres, combined with continuous critical evaluation of established techniques will ensure improved and sustained results. The primary consideration of practising paediatric cardiologists should not be whether it is possible to perform such techniques, but whether their clinical utility, morbidity and mortality justifies a non-surgical approach for their centre. Interventional catheterization, in other words has to "compete' with the results of surgery prior to new techniques being recommended for general use. Despite this "competition' it has been welcome to see a collaboration between paediatric cardiologists and paediatric cardiac surgeons in planning staged repairs of complex congenital heart disease. A typical example of this is the fenestrated Fontan procedure, in which the immediate post-operative course has dramatically improved due to the deliberate placement of a residual atrial shunt, which is then closed with an umbrella in the catheter laboratory. This type of cooperation is bound to increase further and is already contributing to a far better outcome for many of the complex congenital heart lesions.

摘要

介入治疗在某些先天性心脏病管理中的主要作用已得到确立,其临床应用价值也日益广泛。过去相对粗糙的治疗方法已被安全且更有效的技术所取代。专门设计的儿科设备的改进和新发展起到了重要作用。为了满足心脏病专家改进现有技术和开发新技术的需求,必须对儿科心脏导管设备进行进一步投资。未来,越来越多的“心脏手术”将在心脏导管实验室进行,这将对成本产生明显影响,因为大多数非手术技术比手术便宜,且住院时间短得多。在专业中心的研究方案中进行测试的新方法,与对现有技术的持续严格评估相结合,将确保取得更好且持续的效果。执业儿科心脏病专家的首要考虑不应是是否能够实施此类技术,而应是其临床应用价值、发病率和死亡率是否证明该中心采用非手术方法是合理的。换句话说,在推荐新技术普遍应用之前,介入导管治疗必须与手术效果“竞争”。尽管存在这种“竞争”,但看到儿科心脏病专家和儿科心脏外科医生在规划复杂先天性心脏病的分期修复方面展开合作,还是令人欣慰的。一个典型例子是开窗式Fontan手术,由于特意放置了残余心房分流,术后即刻病程得到了显著改善,随后在导管实验室用伞封堵分流。这种合作必然会进一步增加,并已为许多复杂先天性心脏病变带来了更好的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验